Cardiovascular Risk Reduction: With the 2023 approval for reducing major adverse cardiovascular events, GLP-1 receptor agonists are now used within comprehensive cardiovascular risk-management strategies for patients with type 2 diabetes and established cardiovascular disease
If somebody has blood glucose that is really poorly controlled, and then they get really well controlled rapidly [with GLP-1s], that can actually cause flares of retinopathy, said Ferris
The obesity epidemic and the arrival of next-generation anti-obesity medications (incretin-based therapies) The obesity epidemic: A global health issue Obesity is a multifactorial, chronic disease with significant consequences for physical and psychological wellbeing
Add broccoli florets and cubed sweet potato to the pan
The mRNA level of PK , another key glycolysis-related gene, was decreased in the muscle, and the decrease was significant in the feeding state (Fig
In chronic conditions such as type 2 diabetes and obesity, treatments that fit into everyday routines may be easier to stay on